SCHEMBL8963574

SCHEMBL8963574

CC(=O)c1nc(C2CC2)[nH]c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
HTR2B P41595 2/20 0.40
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
PIN1 Q13526 1/20 0.38
MDM2 Q00987 1/20 0.38
ADORA3 P0DMS8 2/20 0.37
ADORA1 P30542 2/20 0.37
MAPK14 Q16539 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA2A P29274 1/20 0.37
SOAT1 P35610 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4753564 0.80 ERCC1 (0.45) SMN1; SMN2KDM4EALDH1A1HPGDADORA3
SCHEMBL4749731 0.79 ERCC1 (0.44) SMN1; SMN2KDM4EALDH1A1HPGDADORA3
SCHEMBL4750309 0.79 ERCC1 (0.44) SMN1; SMN2KDM4EALDH1A1HPGDADORA3
SCHEMBL7991847 0.72 ADORA1 (0.47) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL15946973 0.72 ESR1 (0.54) SMN1; SMN2KDM4EALDH1A1GLAGAA
Hydrochloric Acid SCHEMBL8963812 0.70 ALDH1A1 (0.39) PDE2AHTR2BKDM4EALDH1A1HPGD
SCHEMBL9517058 0.69 RAF1 (0.62) SMN1; SMN2KDM4EHPGDADORA3ADORA1
SCHEMBL9514583 0.68 RAF1 (0.64) ADORA3ADORA1MAPK14ADORA2BADORA2A
SCHEMBL29722719 0.68 SMN1; SMN2 (0.48) SMN1; SMN2KDM4EALDH1A1MDM2
SCHEMBL9735719 0.67 SOAT1 (0.61) SMN1; SMN2KDM4EALDH1A1HPGDMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed